Literature DB >> 18198241

Hypomania with agitation associated with varenicline use in bipolar II disorder.

Anne E Morstad, Eric C Kutscher, W Klugh Kennedy, Ryan M Carnahan.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2008        PMID： 18198241     DOI： 10.1345/aph.1K511

Source DB:  PubMed          Journal:  Ann Pharmacother        ISSN： 1060-0280            Impact factor:   3.154


× No keyword cloud information.
  15 in total

1.  Effects of sazetidine-A, a selective alpha4beta2 nicotinic acetylcholine receptor desensitizing agent on alcohol and nicotine self-administration in selectively bred alcohol-preferring (P) rats.

Authors:  Amir H Rezvani; Susan Slade; Cori Wells; Ann Petro; Lawrence Lumeng; Ting-Kai Li; Yingxian Xiao; Milton L Brown; Mikell A Paige; Brian E McDowell; Jed E Rose; Kenneth J Kellar; Edward D Levin
Journal:  Psychopharmacology (Berl)       Date:  2010-06-10       Impact factor: 4.530

Review 2.  The co-occurrence of cigarette smoking and bipolar disorder: phenomenology and treatment considerations.

Authors:  Jaimee L Heffner; Jeffrey R Strawn; Melissa P DelBello; Stephen M Strakowski; Robert M Anthenelli
Journal:  Bipolar Disord       Date:  2011 Aug-Sep       Impact factor: 6.744

3.  Smoking cessation: the psychiatrist's role.

Authors:  Nicholas J Delva
Journal:  J Psychiatry Neurosci       Date:  2008-09       Impact factor: 6.186

4.  Psychiatric adverse events in randomized, double-blind, placebo-controlled clinical trials of varenicline: a pooled analysis.

Authors:  Serena Tonstad; Simon Davies; Martina Flammer; Cristina Russ; John Hughes
Journal:  Drug Saf       Date:  2010-04-01       Impact factor: 5.606

5.  Smoking cessation after brain damage does not lead to increased depression: implications for understanding the psychiatric complications of varenicline.

Authors:  Daniel Tranel; Ashton McNutt; Antoine Bechara
Journal:  Cogn Behav Neurol       Date:  2012-03       Impact factor: 1.600

Review 6.  Varenicline for tobacco dependence: panacea or plight?

Authors:  Jill M Williams; Michael B Steinberg; Marc L Steinberg; Kunal K Gandhi; Rajiv Ulpe; Jonathan Foulds
Journal:  Expert Opin Pharmacother       Date:  2011-06-06       Impact factor: 3.889

7.  The smoking cessation drug varenicline improves deficient P20-N40 inhibition in DBA/2 mice.

Authors:  Kristin M Wildeboer-Andrud; Karen E Stevens
Journal:  Pharmacol Biochem Behav       Date:  2011-07-07       Impact factor: 3.533

8.  Late-life Onset Mania After Varenicline Use: A Case Report.

Authors:  Abdullah Akpinar; Gülin Özdamar Ünal; İnci Meltem Atay; Duru Gündoğar; Ramazan Özçankaya
Journal:  Noro Psikiyatr Ars       Date:  2013-12-01       Impact factor: 1.339

9.  An algorithm for tailoring pharmacotherapy for smoking cessation: results from a Delphi panel of international experts.

Authors:  P Bader; P McDonald; P Selby
Journal:  Tob Control       Date:  2008-10-09       Impact factor: 7.552

10.  Visual hallucinations associated with varenicline: a case report.

Authors:  B Mahendri Raidoo; Eric C Kutscher
Journal:  J Med Case Rep       Date:  2009-05-08
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.